Key result
A combined genome-wide linkage and association approach identified several genomic regions linked to aspirin response factors, including significant linkage on chromosome 5q11.2 to post-aspirin platelet response to ADP in African Americans.
Why the study?
Does genetic variation influence platelet function phenotypes in response to aspirin in healthy subjects with a family history of premature CAD?
Observational (n=2,077)
Does genetic variation influence platelet function phenotypes in response to aspirin in healthy subjects with a family history of premature CAD?
Platelet responsiveness to aspirin is likely under genetic control, with specific loci such as a region on chromosome 5q11.2 identified as influencing post-aspirin platelet response.
Answers are grounded in this paper and cite their sources.
Identified platelet response loci in CAD families warrant replication; leaves open whether genetics can guide aspirin responsiveness in practice.
BACKGROUND: The inability of aspirin (ASA) to adequately suppress platelet aggregation is associated with future risk of coronary artery disease (CAD). Heritability studies of agonist-induced platelet function phenotypes suggest that genetic variation may be responsible for ASA responsiveness. In this study, we leverage independent information from genome-wide linkage and association data to determine loci controlling platelet phenotypes before and after treatment with ASA. METHODS: Clinical data on 37 agonist-induced platelet function phenotypes were evaluated before and after a 2-week trial of ASA (81 mg/day) in 1231 European American and 846 African American healthy subjects with a family history of premature CAD. Principal component analysis was performed to minimize the number of independent factors underlying the covariance of these various phenotypes. Multi-point sib-pair based linkage analysis was performed using a microsatellite marker set, and single-SNP association tests were performed using markers from the Illumina 1 M genotyping chip from deCODE Genetics, Inc. All analyses were performed separately within each ethnic group. RESULTS: Several genomic regions appear to be linked to ASA response factors: a 10 cM region in African Americans on chromosome 5q11.2 had several STRs with suggestive (p-value < 7 x 10-4) and significant (p-value < 2 x 10-5) linkage to post aspirin platelet response to ADP, and ten additional factors had suggestive evidence for linkage (p-value < 7 x 10-4) to thirteen genomic regions. All but one of these factors were aspirin response variables. While the strength of genome-wide SNP association signals for factors showing evidence for linkage is limited, especially at the strict thresholds of genome-wide criteria (N = 9 SNPs for 11 factors), more signals were considered significant when the association signal was weighted by evidence for linkage (N = 30 SNPs). CONCLUSIONS: Our study supports the hypothesis that platelet phenotypes in response to ASA likely have genetic control and the combined approach of linkage and association offers an alternative approach to prioritizing regions of interest for subsequent follow-up.
No takes yet. Share an insight, caveat, or question.
Mathias et al. (2010) conducted an observational in Family history of premature coronary artery disease (n=2,077). Genetic variants (SNPs and STRs) vs. Reference alleles was evaluated on Linkage to post-aspirin platelet response to ADP (p=< 2 × 10-5). A combined genome-wide linkage and association approach identified several genomic regions linked to aspirin response factors, including significant linkage on chromosome 5q11.2 to post-aspirin platelet response to ADP in African Americans.
Synapse has enriched 10 related papers. Consider them for comparative context: